Foveal hypoplasia-presenile cataract syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2253OMIM:136520H26.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Foveal hypoplasia-presenile cataract syndrome is an extremely rare genetic eye disorder characterized by the combination of underdevelopment of the fovea (foveal hypoplasia) and early-onset cataracts (presenile cataracts). The fovea is the central part of the retina responsible for sharp, detailed central vision, and its incomplete development leads to reduced visual acuity from birth or early life. Presenile cataracts refer to clouding of the lens that occurs at an unusually young age, typically before the age commonly associated with age-related cataracts. Together, these features result in significant visual impairment. The condition primarily affects the eyes, with patients experiencing reduced central vision due to foveal hypoplasia and progressive visual deterioration from cataract formation. Nystagmus (involuntary rhythmic eye movements) may also be present as a consequence of the foveal underdevelopment. The syndrome has been reported in a very limited number of families in the medical literature. Treatment is primarily supportive and symptomatic. Cataract surgery may be performed when lens opacities significantly impair vision, though visual outcomes may be limited by the underlying foveal hypoplasia. Low-vision aids and optical correction can help optimize remaining visual function. There is currently no specific treatment to correct the foveal underdevelopment. Regular ophthalmological follow-up is recommended to monitor cataract progression and manage visual needs.

Also known as:

Clinical phenotype terms— hover any for plain English:

Generalized hyperpigmentationHP:0007440
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Foveal hypoplasia-presenile cataract syndrome.

View clinical trials →

No actively recruiting trials found for Foveal hypoplasia-presenile cataract syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Foveal hypoplasia-presenile cataract syndrome community →

No specialists are currently listed for Foveal hypoplasia-presenile cataract syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Foveal hypoplasia-presenile cataract syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Foveal hypoplasia-presenile cataract syndromeForum →

No community posts yet. Be the first to share your experience with Foveal hypoplasia-presenile cataract syndrome.

Start the conversation →

Latest news about Foveal hypoplasia-presenile cataract syndrome

No recent news articles for Foveal hypoplasia-presenile cataract syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Foveal hypoplasia-presenile cataract syndrome

What is Foveal hypoplasia-presenile cataract syndrome?

Foveal hypoplasia-presenile cataract syndrome is an extremely rare genetic eye disorder characterized by the combination of underdevelopment of the fovea (foveal hypoplasia) and early-onset cataracts (presenile cataracts). The fovea is the central part of the retina responsible for sharp, detailed central vision, and its incomplete development leads to reduced visual acuity from birth or early life. Presenile cataracts refer to clouding of the lens that occurs at an unusually young age, typically before the age commonly associated with age-related cataracts. Together, these features result in

How is Foveal hypoplasia-presenile cataract syndrome inherited?

Foveal hypoplasia-presenile cataract syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Foveal hypoplasia-presenile cataract syndrome typically begin?

Typical onset of Foveal hypoplasia-presenile cataract syndrome is childhood. Age of onset can vary across affected individuals.